AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 68 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $64,000 | +106.5% | 102,477 | +848.9% | 0.00% | – |
| Q1 2018 | $31,000 | -62.7% | 10,800 | -63.6% | 0.00% | – |
| Q4 2017 | $83,000 | -49.1% | 29,665 | -68.3% | 0.00% | -100.0% |
| Q2 2015 | $163,000 | +17.3% | 93,492 | -2.6% | 0.00% | 0.0% |
| Q1 2015 | $139,000 | +120.6% | 95,978 | +177.8% | 0.00% | – |
| Q2 2014 | $63,000 | -48.8% | 34,550 | -58.0% | 0.00% | -100.0% |
| Q1 2014 | $123,000 | -57.6% | 82,235 | -47.8% | 0.00% | -50.0% |
| Q4 2013 | $290,000 | +1060.0% | 157,438 | +1203.3% | 0.00% | – |
| Q3 2013 | $25,000 | -37.5% | 12,080 | -25.3% | 0.00% | – |
| Q2 2013 | $40,000 | – | 16,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |